Central Library

Pagliari, M.T.; Budde, U.; Baronciani, L.; Eshghi, P.; Ahmadinejad, M.; Badiee, Z.; Baghaipour, M.-R.; Hidalgo, O.B.; Biguzzi, E.; Bodó, I.; Castaman, G.; Goudemand, J.; Karimi, M.; Keikhaei, B.; Lassila, R.; Leebeek, F.W.G.; Lopez, Fernandez M.F.; Marino, R.; Oldenburg, J.; Peake, I.; Santoro, C.; Schneppenheim, R.; Tiede, A.; Toogeh, G.; Tosetto, A.; Trossaert, M.; Yadegari, H.; Zetterberg, E.M.K.; Mannucci, P.M.; Federici, A.B.; Eikenboom, J.; Peyvandi, F.;

D1

JOURNAL OF THROMBOSIS AND HAEMOSTASIS 1538-7933 1538-7836

2023.

DOI:10.1016/j.jtha.2023.01.001 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

5.

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype

Rodeghiero, F;Ghiotto, L;Pontalto, L;Casini, A;Castaman, G;Abdul-Kadir, R;Berntorp, E;Bodó, I;Degenaar-Dujardin, M;Fijnvandraat, K;Gresele, P;Key, NS;Lassila, R;Leebeek, FWG;Lillicrap, D;Makris, M;Meijer, S;Mezzano, D;Noris, P;Pabinger, I;Ragni, MV;Silva, D;Srivastava, A;Tosetto, A;Windyga, J;Zieger, B

Q1

HEMASPHERE

2025.

DOI:10.1002/hem3.70111 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

6.

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

Pulanic, D;Batorova, A;Bodo, I;Cervinek, L;Ionita, I;Lissitchkov, T;Melikyan, A;Podolak-Dawidziak, M

Q1

ANNALS OF HEMATOLOGY

2023.

DOI:10.1007/s00277-023-05114-8 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika, III. Department of Internal Medicine,

7.

Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Baronciani, L;Peake, I;Schneppenheim, R;Goodeve, A;Ahmadinejad, M;Badiee, Z;Baghaipour, MR;Benitez, O;Bodó, I;Budde, U;Cairo, A;Castaman, G;Eshghi, P;Goudemand, J;Hassenpflug, W;Hoorfar, H;Karimi, M;Keikhaei, B;Lassila, R;Leebeek, FWG;Fernandez, MFL;Mannucci, PM;Marino, R;Niksic, N;Oyen, F;Santoro, C;Tiede, A;Toogeh, G;Tosetto, A;Trossaert, M;Zetterberg, EMK;Eikenboom, J;Federici, AB;Peyvandi, F

D1

BLOOD ADVANCES

2021.

DOI:10.1182/bloodadvances.2020003397 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

8.

Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

Tosetto, A;Badiee, Z;Baghaipour, MR;Baronciani, L;Battle, J;Berntorp, E;Bodó, I;Budde, U;Castaman, G;Eikenboom, JCJ;Eshghi, P;Ettorre, C;Goodeve, A;Goudemand, J;Richard, C;Hay, M;Hoorfar, H;Karimi, M;Keikhaei, B;Lassila, R;Leebeek, FWG;Fernandez, MFL;Mannucci, PM;Mazzucconi, MG;Morfini, M;Oldenburg, J;Peake, I;Lòpez, RP;Peyvandi, F;Schneppenheim, R;Tiede, A;Toogeh, G;Trossaert, M;Zekavat, O;Zetterberg, EMK;Federici, AB

D1

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

2020.

DOI:10.1111/jth.14886 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

9.

Matrilineal Composition of the Reconstructed Stock of the Szekler Horse Breed

Gáspárdy, A;Wagenhoffer, Z;Fürlinger, D;Halmágyi, M;Bodó, I;Lancioni, H;Maróti-Agóts, A

Q1

AGRICULTURE-BASEL

2023.

DOI:10.3390/agriculture13020456 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

10.

Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study

Pagliari, MT;Rosendaal, FR;Ahmadinejad, M;Badiee, Z;Baghaipour, MR;Baronciani, L;Hidalgo, OB;Bodó, I;Budde, U;Castaman, G;Eshghi, P;Goudemand, J;Karimi, M;Keikhaei, B;Lassila, R;Leebeek, FWG;Fernandez, MFL;Mannucci, PM;Marino, R;Oldenburg, J;Peake, I;Santoro, C;Schneppenheim, R;Tiede, A;Toogeh, G;Tosetto, A;Trossaert, M;Yadegari, H;Zetterberg, EMK;Peyvandi, F;Federici, AB;Eikenboom, J

D1

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

2022.

DOI:10.1111/jth.15658 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

11.

Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol

Ceglédi, A;Bátai, A;Dolgos, J;Fekete, M;Gopcsa, L;Király, V;Lakatos, G;Nagy, G;Szemlaky, Z;Várkonyi, A;Vilimi, B;Mikala, G;Bodó, I

Q2

PATHOLOGY & ONCOLOGY RESEARCH

2024.

DOI:10.3389/pore.2024.1611720 (Copy DOI)

Semmelweis University authors: Lehoczki, Andrea Marianna, Fekete, Mónika, Nagy, György, Mikala, Gábor, Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Institute for Preventive Medicine and Public Health, Belgyógyászati és Hematológiai Klinika, Department of Internal Medicine and Oncology, Cardiovascular Center, Department of Cardiology – Heart and Vascular Center, School of PhD Studies, Clinical Center of the Semmelweis University, Clinic for Rheumatology and Immunology, Department of Public Health, Department of Rheumatology and Clinical Immunology,

12.

Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx

Carden, MA;Gaddh, M;Hoskote, A;Brown, M;Merrill, V;Stowell, SR;Chandrakasan, S;Antun, A;Kudchadkar, R;Kotanchiyev, S;Jaye, DL;Bodó, I

D1

BLOOD ADVANCES

2020.

DOI:10.1182/bloodadvances.2019001148 (Copy DOI)

Semmelweis University authors: Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika, III. Department of Internal Medicine,

13.

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement

Ceglédi, A;Dolgos, J;Fekete, M;Gopcsa, L;Várkonyi, A;Vilimi, B;Mikala, G;Bodó, I

Q2

PATHOLOGY & ONCOLOGY RESEARCH

2023.

DOI:10.3389/pore.2023.1611250 (Copy DOI)

Semmelweis University authors: Lehoczki, Andrea Marianna, Fekete, Mónika, Mikala, Gábor, Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Institute for Preventive Medicine and Public Health, Belgyógyászati és Hematológiai Klinika, Department of Public Health,

14.

Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers

Szederjesi, A;Baronciani, L;Budde, U;Castaman, G;Colpani, P;Lawrie, AS;Liu, Y;Montgomery, R;Peyvandi, F;Schneppenheim, R;Patzke, J;Bodó, I

D1

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

2020.

DOI:10.1111/jth.14971 (Copy DOI)

Semmelweis University authors: Szederjesi, Attila, Bodó, Imre,

Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

15.

Two B or not two B; the question of bendamustine dosing in low grade lymphoma

Földi, E;Wiedemann, A;Svorenj, S;Szita, VR;Tóth, AD;Tárkányi, I;Feher, A;Kárpáti, A;Horváth, L;Szombath, G;Nagy, Z;Bodó, I;Farkas, P;Masszi, T;Varga, G

Q2

PATHOLOGY & ONCOLOGY RESEARCH

2025.

DOI:10.3389/pore.2025.1612195 (Copy DOI)